Globus Medical Brand Guidelines: A 2003 Spine Start-Up, a Surgical Robot & NuVasive

A spine company from 2003.

Globus Medical was founded in 2003 by David C. Paul, a mechanical engineer who had worked at Synthes, the orthopaedic maker. The Healthcare Technology Report said in July 2019 that Paul founded the company in 2003, took it public in 2012, and had begun his career as an engineer at Synthes before striking out on his own. The company’s own management page says he served as chief executive “from our inception in 2003 until August 2017,” when he became executive chairman, and that his last post at Synthes was director of product development, with responsibility for product development and marketing.

The company is based in Audubon, Pennsylvania, English Wikipedia says, and describes its work as the design, development and commercialisation of products that help surgeons treat patients with musculoskeletal disorders. It began in spine surgery. Today English Wikipedia lists spine, trauma and artificial-joint implants among the products it develops, makes and markets.

The turning point, by the 2019 account, came in 2013, when Paul travelled to Phoenix to see a prototype robot for spinal surgery, the Excelsius GPS. Globus bought the company behind it, Excelsius Surgical, a few months later; English Wikipedia dates the purchase to January 2014. The Healthcare Technology Report says the robot received clearance from the US Food and Drug Administration in August 2017, and ties the company’s growth after 2014 to that purchase.

Leadership has since moved on from the founder. Paul remains executive chairman, and the company’s management page names Keith Pfeil as president and chief executive since July 2025; he previously served as its chief operating officer and chief financial officer, the page says.

Robots, spine and a run of acquisitions.

Globus grew by buying as well as building. English Wikipedia lists a run of purchases after Excelsius: the allograft tissue processor Transplant Technologies of Texas in October 2014; Branch Medical Group, a third-party maker of high-precision medical devices, in February 2015; Nemaris, the developer of the Surgimap pre-operative planning software for spine surgeons, in September 2018; and StelKast, a privately owned maker of implants and instruments for hip and knee replacement, in August 2019. The last of these took Globus into joint replacement.

The robot became a family. The company’s website now groups its enabling technology under the Excelsius name, from the ExcelsiusGPS robotic navigation system to the freehand navigation system ExcelsiusHub and the Excelsius3D imaging system; English Wikipedia says ExcelsiusHub was launched in November 2024. The company calls the group an “ecosystem” of technology for the operating room.

The website sorts the business into five portfolios: spine, orthopaedic trauma, joint reconstruction, a power-tool range and regenerative biologics. In spine it lists procedures from cervical disc replacement to fusion, deformity and paediatric work; in trauma, nailing and plating systems for the upper and lower limbs; in joints, primary and revision hip and knee systems. It describes itself as “a leading global musculoskeletal technology company,” and says its “Advanced Materials Science” work has pioneered ways of combining porosity with PEEK and titanium; both are the company’s own descriptions.

Education is part of the pitch. The company runs the Musculoskeletal Education and Research Center, or MERC, which it says offers training from cadaver laboratories to peer-to-peer preceptorships, alongside an in-house research laboratory for testing techniques and technologies. Its product teams, it says, work in “a rapid design-prototype-test cycle” backed by their own fabrication and testing facilities.

The category.

Orthopaedic device makers sell to a narrow, expert audience: surgeons, theatre teams, hospital buyers and the distributors who serve them. Their brand material is shaped by that audience. Product imagery tends to be precise and technical, with implants rendered as clean metallic objects, often lit against dark or neutral backgrounds so that the form of a stem, a plate or a screw reads clearly.

Clinical imagery sits alongside the renders. X-rays, bone models, anatomical cut-aways and diagrams of a joint or a spinal segment show where a device goes and how it is meant to fit. Many makers also photograph surgeons in theatre, in gowns and masks under surgical lights, and show the trays of instruments that accompany an implant system, laid out in rows that suggest order and completeness.

Education is a large part of the picture. Device makers run training courses, cadaver labs and online technique guides, and much of their visual output is instructional: step-by-step surgical technique documents, animations and videos. Congresses matter too. Large meetings such as the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) and the congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) are where new systems are often shown, on stands designed to carry a brand at scale.

Corporate identities in the field are usually restrained: sans-serif wordmarks, a small set of brand colours and a great deal of white space, with the visual drama left to the product and the clinical image. Many brands also sit inside larger groups, so a single name may appear alongside a parent company’s mark. That makes the typeface, the palette and the treatment of imagery the main tools a maker has for being recognised.

“Life moves us.”

The largest change came in 2023. Globus completed its merger with NuVasive, the San Diego spine company built around the XLIF lateral approach, on 1 September 2023, English Wikipedia says; ORTHOWORLD reported the completion on 5 September. Globus said the combined business would provide “a highly comprehensive offering of musculoskeletal procedural solutions and enabling technologies,” and Dan Scavilla, its chief executive at the time, spoke of creating “a leading global musculoskeletal company.” The XLIF procedure family now appears on Globus’s own website, which says XLIF has helped to shape minimally invasive surgery “for over 20 years.”

The brand language is short and plain. The company’s line is “Life moves us,” followed on its website by “We know that what we do today changes lives tomorrow.” It frames its philosophy as three principles — Providing Exceptional Response, Delivering Innovation and Advancing Patient Care — and says exceptional response starts with understanding surgeons and the challenges they face. Its product names follow a pattern too: one trademarked umbrella, Excelsius, for the robot, navigation and imaging, and procedure names such as XLIF carried over from NuVasive.

Globus is a company founded in 2003 and still chaired by its founder; in 2023 it merged with NuVasive, a spine company incorporated six years earlier, and it has kept NuVasive’s procedure names in use under its own name.

For a design guide, Globus Medical shows how a founder-led spine company can widen into a full musculoskeletal brand while keeping a single name for its technology. Compare DePuy Synthes, whose Synthes side is where Globus’s founder began, and Stryker, the Kalamazoo device maker. For this guide we use a deep navy, a surgical teal and a titanium grey with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Globus Medical’s identity on hand — save it to a board in the Made Good inspiration library.